449 related articles for article (PubMed ID: 27848196)
1. Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.
Ribichini D; Fiorini G; Repaci A; Castelli V; Gatta L; Vaira D; Pasquali R
Endocrine; 2017 Sep; 57(3):394-401. PubMed ID: 27848196
[TBL] [Abstract][Full Text] [Related]
2. The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine.
Bugdaci MS; Zuhur SS; Sokmen M; Toksoy B; Bayraktar B; Altuntas Y
Helicobacter; 2011 Apr; 16(2):124-30. PubMed ID: 21435090
[TBL] [Abstract][Full Text] [Related]
3. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.
Centanni M; Gargano L; Canettieri G; Viceconti N; Franchi A; Delle Fave G; Annibale B
N Engl J Med; 2006 Apr; 354(17):1787-95. PubMed ID: 16641395
[TBL] [Abstract][Full Text] [Related]
4. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
5. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy].
Gietka-Czernel M; Hubalewska-Dydejczyk A; Kos-Kudła B; Lewiński A; Ruchała M; Syrenicz A; Zgliczyński W
Endokrynol Pol; 2020; 71(5):441-465. PubMed ID: 33202031
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Koskenpato J; Färkkilä M; Sipponen P
Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
[TBL] [Abstract][Full Text] [Related]
7. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
Benvenga S; Di Bari F; Vita R
Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
[TBL] [Abstract][Full Text] [Related]
8. [Helicobacter pylori infection in patients with functional dyspepsia, eradication rates in the Donetsk region].
Dorofeev AÉ; Rudenko NN; Agibalov AN; Kugler TE; Sibilev AV; Tomash OV
Lik Sprava; 2014 Nov; (11):119-22. PubMed ID: 25528848
[TBL] [Abstract][Full Text] [Related]
9. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
10. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.
Vita R; Saraceno G; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4481-6. PubMed ID: 25259910
[TBL] [Abstract][Full Text] [Related]
11. Levothyroxine liquid solution versus tablet form for replacement treatment in pregnant women.
Cappelli C; Negro R; Pirola I; Gandossi E; Agosti B; Castellano M
Gynecol Endocrinol; 2016; 32(4):290-2. PubMed ID: 26585420
[TBL] [Abstract][Full Text] [Related]
12. Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.
Brancato D; Scorsone A; Saura G; Ferrara L; Di Noto A; Aiello V; Fleres M; Provenzano V
Endocr Pract; 2014 Jul; 20(7):657-62. PubMed ID: 24449674
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.
Caron P; Grunenwald S; Persani L; Borson-Chazot F; Leroy R; Duntas L
Rev Endocr Metab Disord; 2022 Jun; 23(3):463-483. PubMed ID: 34671932
[TBL] [Abstract][Full Text] [Related]
14. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
Kyzekové J; Arlt J; Arltová M
Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
Matsukawa Y; Kato K; Hatta Y; Iwamoto M; Mizuno S; Kurihara R; Arakawa Y; Kurosaka H; Hayashi I; Sawada S
Platelets; 2007 Feb; 18(1):52-5. PubMed ID: 17365854
[TBL] [Abstract][Full Text] [Related]
16. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
17. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
18. Influence of Helicobacter pylori infection and the effects of its eradication on gastric emptying in non-ulcerative dyspepsia.
Murakami K; Fujioka T; Shiota K; Ito A; Fujiyama K; Kodama R; Kawasaki Y; Kubota T; Nasu M
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S93-7. PubMed ID: 8574747
[TBL] [Abstract][Full Text] [Related]
19. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
20. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
Pilotto A; Perri F; Leandro G; Franceschi M;
Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
